Detalhe da pesquisa
1.
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.
Blood
; 133(20): 2121-2129, 2019 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770396
2.
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL.
Blood
; 131(16): 1805-1808, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29386196
3.
Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.
Blood
; 130(20): 2196-2203, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874350
4.
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma.
Blood
; 128(11): 1458-64, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458003
5.
B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins.
Blood
; 123(10): 1512-5, 2014 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-24449209
6.
Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies.
PLoS Genet
; 9(1): e1003220, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23349640
7.
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study.
Lancet Oncol
; 16(3): 284-92, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25683846
8.
Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.
Cancer
; 121(12): 1985-92, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25739719
9.
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma.
Blood
; 119(7): 1665-70, 2012 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22184409
10.
Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma.
Haematologica
; 104(4): e163-e166, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30930338
11.
ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study.
Haematologica
; 104(2): e65-e67, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190343
12.
Matched control analysis suggests that R-CHOP followed by (R)-ICE may improve outcome in non-GCB DLBCL compared with R-CHOP.
Blood Adv
; 8(9): 2172-2181, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271621
13.
ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma.
Cancer
; 119(6): 1203-9, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23132361
14.
Hepatitis C and non-Hodgkin lymphoma: the clinical perspective.
Hepatology
; 55(2): 634-41, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22120959
15.
Long-term cardiac and pulmonary complications of cancer therapy.
Heart Fail Clin
; 7(3): 403-11, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21749892
16.
Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue.
Blood Adv
; 5(2): 345-351, 2021 01 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33496731
17.
Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patients.
Blood Adv
; 5(7): 1830-1836, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33787863
18.
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging.
Br J Haematol
; 148(6): 890-7, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20085577
19.
Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation.
Biol Blood Marrow Transplant
; 15(12): 1538-42, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19896077
20.
Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma.
Br J Haematol
; 146(6): 652-5, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19624539